M C Boffa Selected Research

Anti-Bacterial Agents (Antibiotics)

1/2003

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M C Boffa Research Topics

Disease

2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2003 - 01/2003
2	Thrombosis (Thrombus) 01/2003 - 02/2001
1	Hypersensitivity (Allergy) 01/2003
1	Infections 01/2003
1	Cytokine Release Syndrome 01/2003
1	Fever (Fevers) 02/2001
1	Hemolytic Anemia 02/2001
1	Thrombotic Thrombocytopenic Purpura 02/2001
1	Thrombocytopenia (Thrombopenia) 02/2001
1	Neoplasms (Cancer) 03/2000

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 09/2003 - 02/2001
1	Peptides (Polypeptides)IBA 09/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2003
1	Warfarin (Coumadin)FDA LinkGeneric 01/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2003
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2003
1	anti-endothelial cell antibodyIBA 02/2001
1	thiamine triphosphorate (TTP)IBA 02/2001
1	AnticoagulantsIBA 03/2000
1	Biological ProductsIBA 03/2000

Therapy/Procedure

1	Surgical Amputation (Amputations) 01/2003
1	Therapeutics 03/2000